Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.

Qiu Z, Lin A, Li K, Lin W, Wang Q, Wei T, Zhu W, Luo P, Zhang J.

Drug Des Devel Ther. 2019 Jun 21;13:2021-2041. doi: 10.2147/DDDT.S205633. eCollection 2019.

2.

Genome-wide association study reveals candidate genes associated with body measurement traits in Chinese Wagyu beef cattle.

An B, Xia J, Chang T, Wang X, Xu L, Zhang L, Gao X, Chen Y, Li J, Gao H.

Anim Genet. 2019 Aug;50(4):386-390. doi: 10.1111/age.12805. Epub 2019 Jun 10.

PMID:
31179577
3.

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.

La Fleur L, Falk-Sörqvist E, Smeds P, Berglund A, Sundström M, Mattsson JS, Brandén E, Koyi H, Isaksson J, Brunnström H, Nilsson M, Micke P, Moens L, Botling J.

Lung Cancer. 2019 Apr;130:50-58. doi: 10.1016/j.lungcan.2019.01.003. Epub 2019 Jan 9.

4.

Integrative analysis of cancer driver genes in prostate adenocarcinoma.

Zhao X, Lei Y, Li G, Cheng Y, Yang H, Xie L, Long H, Jiang R.

Mol Med Rep. 2019 Apr;19(4):2707-2715. doi: 10.3892/mmr.2019.9902. Epub 2019 Jan 28.

5.

Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.

Cuevas D, Valls J, Gatius S, Roman-Canal B, Estaran E, Dorca E, Santacana M, Vaquero M, Eritja N, Velasco A, Matias-Guiu X.

Virchows Arch. 2019 May;474(5):585-598. doi: 10.1007/s00428-018-02516-2. Epub 2019 Feb 1.

PMID:
30710169
6.

Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.

Zhang P, Kang B, Xie G, Li S, Gu Y, Shen Y, Zhao X, Ma Y, Li F, Si J, Wang J, Chen J, Yang H, Xu X, Yang Y.

Cancer Lett. 2019 Feb 1;442:53-67. doi: 10.1016/j.canlet.2018.10.035. Epub 2018 Oct 27.

7.

Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations.

Somaiah N, Beird HC, Barbo A, Song J, Mills Shaw KR, Wang WL, Eterovic K, Chen K, Lazar A, Conley AP, Ravi V, Hwu P, Futreal A, Simon G, Meric-Bernstam F, Hong D.

Oncotarget. 2018 Apr 13;9(28):19891-19899. doi: 10.18632/oncotarget.24924. eCollection 2018 Apr 13.

8.

Presence of meniscus tear alters gene expression profile of anterior cruciate ligament tears.

Brophy RH, Rothermich MA, Tycksen ED, Cai L, Rai MF.

J Orthop Res. 2018 Oct;36(10):2612-2621. doi: 10.1002/jor.24025. Epub 2018 Jun 13.

9.

Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers.

Wolff RK, Hoffman MD, Wolff EC, Herrick JS, Sakoda LC, Samowitz WS, Slattery ML.

Genes Chromosomes Cancer. 2018 Jul;57(7):366-376. doi: 10.1002/gcc.22539. Epub 2018 Apr 30.

10.

Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations.

Deng J, Chen H, Zhou D, Zhang J, Chen Y, Liu Q, Ai D, Zhu H, Chu L, Ren W, Zhang X, Xia Y, Sun M, Zhang H, Li J, Peng X, Li L, Han L, Lin H, Cai X, Xiang J, Chen S, Sun Y, Zhang Y, Zhang J, Chen H, Zhang S, Zhao Y, Liu Y, Liang H, Zhao K.

Nat Commun. 2017 Nov 16;8(1):1533. doi: 10.1038/s41467-017-01730-x.

11.

Genomic analysis of atypical fibroxanthoma.

Lai K, Harwood CA, Purdie KJ, Proby CM, Leigh IM, Ravi N, Mully TW, Brooks L, Sandoval PM, Rosenblum MD, Arron ST.

PLoS One. 2017 Nov 15;12(11):e0188272. doi: 10.1371/journal.pone.0188272. eCollection 2017.

12.

Two cases of Legg-Perthes and intellectual disability in Tricho-Rhino-Phalangeal syndrome type 1 associated with novel TRPS1 mutations.

Gilman JL, Newman HA, Freeman R, Singh KE, Puckett RL, Morohashi DK, Stein C, Palomino K, Lebel RR, Kimonis VE.

Am J Med Genet A. 2017 Jun;173(6):1663-1667. doi: 10.1002/ajmg.a.38204. Epub 2017 Mar 3.

PMID:
28256045
13.

Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.

Maru Y, Tanaka N, Ohira M, Itami M, Hippo Y, Nagase H.

Gynecol Oncol. 2017 Feb;144(2):377-383. doi: 10.1016/j.ygyno.2016.11.045. Epub 2016 Dec 9.

PMID:
27939411
14.

Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation.

Lai MW, Liang KH, Lin WR, Huang YH, Huang SF, Chen TC, Yeh CT.

Oncogenesis. 2016 Dec 5;5(12):e273. doi: 10.1038/oncsis.2016.77.

15.

Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma.

McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, Wise RA, Szefler SJ, Sharma S, Kho AT, Cho MH, Croteau-Chonka DC, Castaldi PJ, Jain G, Sanyal A, Zhan Y, Lajoie BR, Dekker J, Stamatoyannopoulos J, Covar RA, Zeiger RS, Adkinson NF, Williams PV, Kelly HW, Grasemann H, Vonk JM, Koppelman GH, Postma DS, Raby BA, Houston I, Lu Q, Fuhlbrigge AL, Tantisira KG, Silverman EK, Tonascia J, Strunk RC, Weiss ST; CAMP Research Group.

Am J Respir Crit Care Med. 2016 Dec 15;194(12):1465-1474.

16.

Whole-genome profiling helps to classify phyllodes tumours of the breast.

Laé M, La Rosa P, Mandel J, Reyal F, Hupé P, Terrier P, Couturier J.

J Clin Pathol. 2016 Dec;69(12):1081-1087. doi: 10.1136/jclinpath-2016-203684. Epub 2016 May 20.

PMID:
27207013
17.

CUB and Sushi multiple domains 3 regulates dendrite development.

Mizukami T, Kohno T, Hattori M.

Neurosci Res. 2016 Sep;110:11-7. doi: 10.1016/j.neures.2016.03.003. Epub 2016 Mar 28.

PMID:
27033969
18.

Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.

Al-Hebshi NN, Li S, Nasher AT, El-Setouhy M, Alsanosi R, Blancato J, Loffredo C.

Int J Cancer. 2016 Jul 15;139(2):363-72. doi: 10.1002/ijc.30068. Epub 2016 Mar 18.

19.

Next generation sequencing in synovial sarcoma reveals novel gene mutations.

Vlenterie M, Hillebrandt-Roeffen MH, Flucke UE, Groenen PJ, Tops BB, Kamping EJ, Pfundt R, de Bruijn DR, Geurts van Kessel AH, van Krieken HJ, van der Graaf WT, Versleijen-Jonkers YM.

Oncotarget. 2015 Oct 27;6(33):34680-90. doi: 10.18632/oncotarget.5786.

20.

Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.

Khan FH, Pandian V, Ramraj S, Natarajan M, Aravindan S, Herman TS, Aravindan N.

BMC Cancer. 2015 Jul 10;15:514. doi: 10.1186/s12885-015-1463-y.

Supplemental Content

Loading ...
Support Center